Fenimore Asset Management Inc. decreased its holdings in Waters Co. (NYSE:WAT) by 0.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 297,825 shares of the medical instruments supplier’s stock after selling 1,055 shares during the quarter. Waters makes up 2.2% of Fenimore Asset Management Inc.’s portfolio, making the stock its 16th biggest position. Fenimore Asset Management Inc.’s holdings in Waters were worth $57,537,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in WAT. Dimensional Fund Advisors LP lifted its stake in shares of Waters by 0.7% in the second quarter. Dimensional Fund Advisors LP now owns 209,081 shares of the medical instruments supplier’s stock worth $38,436,000 after acquiring an additional 1,448 shares in the last quarter. HighTower Advisors LLC lifted its stake in shares of Waters by 1.0% in the second quarter. HighTower Advisors LLC now owns 2,280 shares of the medical instruments supplier’s stock worth $420,000 after acquiring an additional 23 shares in the last quarter. BlueCrest Capital Management Ltd lifted its stake in shares of Waters by 326.7% in the second quarter. BlueCrest Capital Management Ltd now owns 6,434 shares of the medical instruments supplier’s stock worth $1,183,000 after acquiring an additional 4,926 shares in the last quarter. Cubist Systematic Strategies LLC lifted its stake in shares of Waters by 140.7% in the second quarter. Cubist Systematic Strategies LLC now owns 5,195 shares of the medical instruments supplier’s stock worth $955,000 after acquiring an additional 3,037 shares in the last quarter. Finally, Raymond James Financial Services Advisors Inc. lifted its stake in shares of Waters by 3.0% in the second quarter. Raymond James Financial Services Advisors Inc. now owns 6,668 shares of the medical instruments supplier’s stock worth $1,226,000 after acquiring an additional 196 shares in the last quarter. Institutional investors and hedge funds own 91.88% of the company’s stock.

In related news, Director William J. Miller sold 3,500 shares of the stock in a transaction that occurred on Tuesday, December 5th. The stock was sold at an average price of $194.94, for a total value of $682,290.00. Following the completion of the transaction, the director now directly owns 25,849 shares of the company’s stock, valued at approximately $5,039,004.06. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Elizabeth B. Rae sold 28,400 shares of the stock in a transaction that occurred on Monday, January 29th. The stock was sold at an average price of $219.01, for a total value of $6,219,884.00. Following the completion of the transaction, the senior vice president now directly owns 13,443 shares of the company’s stock, valued at $2,944,151.43. The disclosure for this sale can be found here. Insiders sold a total of 124,789 shares of company stock valued at $26,083,647 over the last three months. Corporate insiders own 5.07% of the company’s stock.

Several research firms recently commented on WAT. Barclays boosted their price target on Waters from $188.00 to $193.00 and gave the stock an “equal weight” rating in a research note on Wednesday, October 25th. Janney Montgomery Scott boosted their price objective on Waters from $200.00 to $230.00 and gave the company a “buy” rating in a report on Wednesday, January 24th. Zacks Investment Research raised Waters from a “hold” rating to a “buy” rating and set a $211.00 price objective for the company in a report on Monday, October 23rd. William Blair reissued an “outperform” rating on shares of Waters in a report on Tuesday, January 23rd. Finally, Citigroup boosted their price objective on Waters from $190.00 to $223.00 and gave the company a “neutral” rating in a report on Wednesday, January 24th. Twelve analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $203.75.

Waters Co. (WAT) opened at $191.79 on Friday. The company has a market capitalization of $16,064.08, a P/E ratio of 26.93, a PEG ratio of 2.42 and a beta of 0.88. Waters Co. has a fifty-two week low of $147.20 and a fifty-two week high of $220.20. The company has a current ratio of 2.10, a quick ratio of 1.97 and a debt-to-equity ratio of 0.66.

Waters (NYSE:WAT) last issued its quarterly earnings data on Tuesday, January 23rd. The medical instruments supplier reported $2.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.44 by $0.07. Waters had a return on equity of 24.70% and a net margin of 0.88%. The business had revenue of $687.28 million during the quarter, compared to analyst estimates of $671.98 million. During the same period in the prior year, the company posted $2.21 EPS. The business’s revenue for the quarter was up 9.3% compared to the same quarter last year. sell-side analysts predict that Waters Co. will post 8.16 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Waters Co. (WAT) Position Lowered by Fenimore Asset Management Inc.” was first reported by Daily Political and is owned by of Daily Political. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.dailypolitical.com/2018/02/09/waters-co-wat-position-lowered-by-fenimore-asset-management-inc.html.

Waters Profile

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.